Weekly Analysts’ Ratings Changes for The Cigna Group (CI)

A number of firms have modified their ratings and price targets on shares of The Cigna Group (NYSE: CI) recently:

• 11/5/2024 – The Cigna Group had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $394.00 price target on the stock, up previously from $392.00.
• 11/5/2024 – The Cigna Group had its price target raised by analysts at Barclays PLC from $405.00 to $420.00. They now have an “overweight” rating on the stock.
• 11/4/2024 – The Cigna Group was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating.
• 11/4/2024 – The Cigna Group had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $398.00 to $394.00. They now have a “buy” rating on the stock.
• 11/1/2024 – The Cigna Group had its “overweight” rating reaffirmed by analysts at Stephens. They now have a $410.00 price target on the stock.
• 11/1/2024 – The Cigna Group had its price target lowered by analysts at Royal Bank of Canada from $384.00 to $377.00. They now have an “outperform” rating on the stock.
• 10/23/2024 – The Cigna Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $400.00 price target on the stock.
• 10/1/2024 – The Cigna Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $400.00 price target on the stock.
• 9/17/2024 – The Cigna Group had its price target raised by analysts at Jefferies Financial Group Inc. from $402.00 to $422.00. They now have a “buy” rating on the stock.
• 9/16/2024 – The Cigna Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $400.00 price target on the stock.

The Cigna Group Trading Down 2.4 %

Shares of The Cigna Group stock traded down $8.12 during trading hours on Wednesday, reaching $331.75. 1,675,473 shares of the company’s stock were exchanged, compared to its average volume of 1,543,780. The Cigna Group has a 52-week low of $253.95 and a 52-week high of $370.83. The firm has a market capitalization of $92.28 billion, a price-to-earnings ratio of 31.30, a price-to-earnings-growth ratio of 1.02 and a beta of 0.51. The company has a fifty day moving average of $340.84 and a 200-day moving average of $340.08. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71.

The Cigna Group (NYSE:CI) last issued its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion for the quarter, compared to analysts’ expectations of $59.58 billion. During the same quarter last year, the firm earned $6.77 earnings per share. The firm’s revenue for the quarter was up 29.8% compared to the same quarter last year. Sell-side analysts forecast that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be given a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.69%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 52.83%.

Insider Transactions at The Cigna Group

In other news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now directly owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On The Cigna Group

A number of hedge funds have recently bought and sold shares of CI. Cedar Wealth Management LLC acquired a new position in The Cigna Group in the first quarter valued at approximately $29,000. TruNorth Capital Management LLC acquired a new position in shares of The Cigna Group during the second quarter worth approximately $33,000. Ulland Investment Advisors LLC boosted its position in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares during the period. Prospera Private Wealth LLC acquired a new position in shares of The Cigna Group during the third quarter worth approximately $37,000. Finally, Harbor Capital Advisors Inc. acquired a new position in shares of The Cigna Group during the third quarter worth approximately $45,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.